| Metric | შპს მედელ საქართველო | შპს ნეოფარმი + |
|---|---|---|
| Growth | ||
| Revenue | ₾16.3m₾5.3m | ₾16.3m₾13.9m |
| Revenue growth | 206.5% | 17.4% |
| Profitability | ||
| EBITDA | ₾5.6m₾2.2m | -₾751k-₾1.2m |
| EBITDA margin | 34.0%41.9% | -4.6%-8.4% |
| Net profit | ₾5.5m₾2.2m | -₾873k-₾1.3m |
| Net margin | 33.5%41.9% | -5.4%-9.1% |
| Balance sheet | ||
| Total assets | ₾2.2m₾233k | ₾5.7m₾6.3m |
| Total equity | ₾797k₾15k | ₾14k₾887k |
| ROE | 685.3%15402.6% | -6150.6%-142.2% |